These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 23054648)
41. [Clinical and genetic features of a patient with myeloid neoplasm in association with PDGFRA and EVI1 gene rearrangements]. Han W; Chao H; Zhou M; Cen L; Chen S; He X; Lu X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):93-97. PubMed ID: 28186604 [TBL] [Abstract][Full Text] [Related]
42. High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide. Jonasova A; Bokorova R; Polak J; Vostry M; Kostecka A; Hajkova H; Neuwirtova R; Siskova M; Sponerova D; Cermak J; Mikulenkova D; Cervinek L; Brezinova J; Michalova K; Fuchs O Eur J Haematol; 2015 Jul; 95(1):27-34. PubMed ID: 25284710 [TBL] [Abstract][Full Text] [Related]
43. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia. Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371 [TBL] [Abstract][Full Text] [Related]
44. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Yamazaki H; Suzuki M; Otsuki A; Shimizu R; Bresnick EH; Engel JD; Yamamoto M Cancer Cell; 2014 Apr; 25(4):415-27. PubMed ID: 24703906 [TBL] [Abstract][Full Text] [Related]
45. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314 [TBL] [Abstract][Full Text] [Related]
46. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162 [TBL] [Abstract][Full Text] [Related]
47. Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case. Palacios-Campos A; Gutierrez O; Fabian-Morales E; Avilés A; Candelaria M Rev Med Chil; 2020 Sep; 148(9):1357-1361. PubMed ID: 33399713 [TBL] [Abstract][Full Text] [Related]
49. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia. Wieser R; Lechner K; Valent P; Fonatsch C Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000 [No Abstract] [Full Text] [Related]
50. The EVI1 gene in myeloid leukemia. Nucifora G Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815 [TBL] [Abstract][Full Text] [Related]
51. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414 [TBL] [Abstract][Full Text] [Related]
52. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26). De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759 [TBL] [Abstract][Full Text] [Related]
53. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia. Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821 [TBL] [Abstract][Full Text] [Related]
54. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops. Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081 [TBL] [Abstract][Full Text] [Related]
55. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22. De Weer A; Speleman F; Cauwelier B; Van Roy N; Yigit N; Verhasselt B; De Moerloose B; Benoit Y; Noens L; Selleslag D; Lippert E; Struski S; Bastard C; De Paepe A; Vandenberghe P; Hagemeijer A; Dastugue N; Poppe B; Haematologica; 2008 Dec; 93(12):1903-7. PubMed ID: 18815193 [TBL] [Abstract][Full Text] [Related]
56. Genomic dark matter sheds light on EVI1-driven leukemia. Koche RP; Armstrong SA Cancer Cell; 2014 Apr; 25(4):407-8. PubMed ID: 24735919 [TBL] [Abstract][Full Text] [Related]
57. EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22). De Weer A; Poppe B; Cauwelier B; Carlier A; Dierick J; Verhasselt B; Philippé J; Van Roy N; Speleman F BMC Cancer; 2008 Jul; 8():193. PubMed ID: 18613965 [TBL] [Abstract][Full Text] [Related]
58. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia. Pekarsky Y; Rynditch A; Wieser R; Fonatsch C; Gardiner K Cancer Res; 1997 Sep; 57(18):3914-9. PubMed ID: 9307271 [TBL] [Abstract][Full Text] [Related]
59. Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13). Nakamura Y; Nakazato H; Sato Y; Furusawa S; Mitani K Am J Hematol; 2002 Jan; 69(1):80-2. PubMed ID: 11835339 [TBL] [Abstract][Full Text] [Related]
60. Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny. Rossbach HC; Sutcliffe MJ; Chamizo W; Haag MM; Grana NH; Washington KR; Barbosa JL J Pediatr Hematol Oncol; 1998; 20(4):347-52. PubMed ID: 9703011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]